BRPI0821467A2 - Composição, e, métodos pra produzir furina recombinante substancialmente livre de proteína animal, e para utilizar uma composição - Google Patents

Composição, e, métodos pra produzir furina recombinante substancialmente livre de proteína animal, e para utilizar uma composição

Info

Publication number: BRPI0821467A2
Authority: BR; Brazil
Prior art keywords: furina; composition; methods; substantially free; animal protein
Prior art date: 2007-12-31

Application number

Other languages

English (en)

Inventor

Barbara Plaimauer

Simone Von Fircks

Leopold Grillberger

Meinhard Hasslacher

Arthur Mitterer

Manfred Reiter

Original Assignee

Baxter Int

Baxter Healthcare Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-12-31

Filing date

2008-12-19

Publication date

2014-10-14

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40524590&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0821467(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2008-12-19 Application filed by Baxter Int, Baxter Healthcare Sa filed Critical Baxter Int

2014-10-14 Publication of BRPI0821467A2 publication Critical patent/BRPI0821467A2/pt

2019-10-15 Publication of BRPI0821467B1 publication Critical patent/BRPI0821467B1/pt

2021-05-25 Publication of BRPI0821467B8 publication Critical patent/BRPI0821467B8/pt

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6454—Dibasic site splicing serine proteases, e.g. kexin (3.4.21.61); furin (3.4.21.75) and other proprotein convertases
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Genetics & Genomics (AREA)
Biomedical Technology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Animal Behavior & Ethology (AREA)
Microbiology (AREA)
Biotechnology (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
General Engineering & Computer Science (AREA)
Hematology (AREA)
Diabetes (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Peptides Or Proteins (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Enzymes And Modification Thereof (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

BRPI0821467A 2007-12-31 2008-12-19 composição de furina recombinante, método para produzir a composição de furina recombinante, e, método para produzir uma proteína madura utilizando a composição de furina recombinante BRPI0821467B8 (pt)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US1815207P	2007-12-31	2007-12-31
US61/018152		2007-12-31
PCT/US2008/087732 WO2009088713A1 (en)	2007-12-31	2008-12-19	Substantially animal protein-free recombinant furin and methods for producing same

Publications (3)

Publication Number	Publication Date
BRPI0821467A2 true BRPI0821467A2 (pt)	2014-10-14
BRPI0821467B1 BRPI0821467B1 (pt)	2019-10-15
BRPI0821467B8 BRPI0821467B8 (pt)	2021-05-25

Family

ID=40524590

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0821467A BRPI0821467B8 (pt)	2007-12-31	2008-12-19	composição de furina recombinante, método para produzir a composição de furina recombinante, e, método para produzir uma proteína madura utilizando a composição de furina recombinante

Country Status (18)

Country	Link
US (2)	US20090181423A1 (pt)
EP (2)	EP3521422B1 (pt)
JP (2)	JP5806465B2 (pt)
KR (1)	KR101618144B1 (pt)
CN (2)	CN110066782B (pt)
AR (2)	AR069892A1 (pt)
AU (1)	AU2008346817B2 (pt)
BR (1)	BRPI0821467B8 (pt)
CA (1)	CA2710260C (pt)
DK (1)	DK2240578T3 (pt)
ES (2)	ES2735173T3 (pt)
HU (1)	HUE043863T2 (pt)
MX (1)	MX2010007344A (pt)
NZ (1)	NZ586411A (pt)
PL (2)	PL2240578T3 (pt)
PT (1)	PT2240578T (pt)
SG (2)	SG192471A1 (pt)
WO (1)	WO2009088713A1 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP2147097A2 (en) *	2007-05-22	2010-01-27	Baxter Int	PREPARATIVE PURIFICATION METHOD FOR HUMAN FURINE
BRPI0821467B8 (pt)	2007-12-31	2021-05-25	Baxalta GmbH	composição de furina recombinante, método para produzir a composição de furina recombinante, e, método para produzir uma proteína madura utilizando a composição de furina recombinante
US8241623B1 (en)	2009-02-09	2012-08-14	David Bermudes	Protease sensitivity expression system
PT3064508T (pt)	2010-07-08	2019-12-05	Baxalta Inc	Método de produção de fvw recombinante de elevado peso molecular na cultura de células
WO2012122611A1 (en) *	2011-03-11	2012-09-20	Universidade De São Paulo - Usp	Method for the production of recombinant human factor viii
WO2012167271A1 (en)	2011-06-02	2012-12-06	Baxter International Inc.	Formulations of recombinant furin
TWI666319B (zh) *	2014-08-12	2019-07-21	美商巴克斯歐塔公司	在分泌ｆｕｒｉｎ之哺乳動物表現系統中生產經完全加工且具功能性之因子Ｘ
IL253071B2 (en)	2014-12-22	2024-04-01	Genzyme Corp	Methods for growing mammalian cells
US11299533B2 (en)	2017-06-23	2022-04-12	Takeda Pharmaceutical Company Limited	Purification of factor VIII subspecies

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US1815207A (en)	1929-01-18	1931-07-21	John H Moffat	Vehicle parking and locking device
NL9000917A (nl)	1989-10-25	1991-05-16	Holland Biotechnology	Farmaceutisch preparaat met endoproteolytische activiteit; werkwijze voor endoproteolytische processing van (precursor) eiwitten en voor de (micro) biologische bereiding van eiwitten.
ES2109336T3 (es)	1990-11-26	1998-01-16	Genetics Inst	Expresion de pace en celulas huesped y metodos de utilizacion de la misma.
US5604201A (en) *	1993-01-08	1997-02-18	State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education On Behalf Of The Oregon Health Sciences University, A Non-Profit Organization	Methods and reagents for inhibiting furin endoprotease
AT404838B (de) *	1995-11-24	1999-03-25	Immuno Ag	Herstellung von proteinen aus pro-proteinen durch fusionsproteine abgeleitet von furin oder furinanalogen
EP1983044B1 (en)	1996-10-10	2016-08-10	Life Technologies Corporation	Animal cell culture media comprising plant-derived nutrients
AT407750B (de)	1999-02-19	2001-05-25	Immuno Ag	Verfahren zur herstellung einer vwf-präparation
US6596526B1 (en) *	2000-06-09	2003-07-22	Baxter Aktiengesellschaft	Furin polypeptides with improved characteristics
SE0103084D0 (sv) *	2001-09-14	2001-09-14	Amersham Pharm Biotech Ab	Generation of ion exchange media
US20030091976A1 (en)	2001-11-14	2003-05-15	Ciphergen Biosystems, Inc.	Methods for monitoring polypeptide production and purification using surface enhanced laser desorption/ionization mass spectrometry
PT2287288E (pt) *	2002-07-09	2012-12-10	Baxter Int	Meio isento de proteína animal para cultura de células
NZ548126A (en) *	2004-02-27	2009-10-30	Ge Healthcare Bio Sciences Ab	A process for the purification of antibodies involving addition of a second resin
WO2007077217A2 (en) *	2006-01-04	2007-07-12	Baxter International Inc.	Oligopeptide-free cell culture media
EP2147097A2 (en) *	2007-05-22	2010-01-27	Baxter Int	PREPARATIVE PURIFICATION METHOD FOR HUMAN FURINE
BRPI0821467B8 (pt)	2007-12-31	2021-05-25	Baxalta GmbH	composição de furina recombinante, método para produzir a composição de furina recombinante, e, método para produzir uma proteína madura utilizando a composição de furina recombinante
US9718255B2 (en)	2011-11-03	2017-08-01	Barson Composites Corporation	Corrosion-resistant diffusion coatings

2008
- 2008-12-19 BR BRPI0821467A patent/BRPI0821467B8/pt active IP Right Grant
- 2008-12-19 EP EP19163119.1A patent/EP3521422B1/en active Active
- 2008-12-19 AR ARP080105645 patent/AR069892A1/es active IP Right Grant
- 2008-12-19 HU HUE08869658A patent/HUE043863T2/hu unknown
- 2008-12-19 JP JP2010540818A patent/JP5806465B2/ja active Active
- 2008-12-19 KR KR1020107017148A patent/KR101618144B1/ko active Active
- 2008-12-19 ES ES08869658T patent/ES2735173T3/es active Active
- 2008-12-19 SG SG2013051693A patent/SG192471A1/en unknown
- 2008-12-19 CN CN201811405688.6A patent/CN110066782B/zh active Active
- 2008-12-19 AU AU2008346817A patent/AU2008346817B2/en active Active
- 2008-12-19 ES ES19163119T patent/ES2897561T3/es active Active
- 2008-12-19 SG SG10201805749QA patent/SG10201805749QA/en unknown
- 2008-12-19 NZ NZ586411A patent/NZ586411A/en unknown
- 2008-12-19 WO PCT/US2008/087732 patent/WO2009088713A1/en not_active Ceased
- 2008-12-19 CN CN2008801240838A patent/CN101910401A/zh active Pending
- 2008-12-19 DK DK08869658.8T patent/DK2240578T3/da active
- 2008-12-19 US US12/339,597 patent/US20090181423A1/en not_active Abandoned
- 2008-12-19 PL PL08869658T patent/PL2240578T3/pl unknown
- 2008-12-19 EP EP08869658.8A patent/EP2240578B1/en active Active
- 2008-12-19 PL PL19163119T patent/PL3521422T3/pl unknown
- 2008-12-19 PT PT08869658T patent/PT2240578T/pt unknown
- 2008-12-19 MX MX2010007344A patent/MX2010007344A/es active IP Right Grant
- 2008-12-19 CA CA2710260A patent/CA2710260C/en active Active
2010
- 2010-12-03 US US12/960,093 patent/US9127264B2/en active Active
2015
- 2015-06-03 JP JP2015112866A patent/JP2015154790A/ja not_active Withdrawn
2018
- 2018-12-12 AR ARP180103625A patent/AR113492A2/es unknown

Also Published As

Publication number	Publication date
PL3521422T3 (pl)	2021-12-20
ES2735173T3 (es)	2019-12-16
EP2240578B1 (en)	2019-03-20
US20090181423A1 (en)	2009-07-16
CN101910401A (zh)	2010-12-08
AU2008346817A1 (en)	2009-07-16
DK2240578T3 (da)	2019-06-17
EP2240578A1 (en)	2010-10-20
SG10201805749QA (en)	2018-08-30
CN110066782B (zh)	2024-04-16
CA2710260C (en)	2023-07-11
BRPI0821467B1 (pt)	2019-10-15
JP2015154790A (ja)	2015-08-27
CA2710260A1 (en)	2009-07-16
NZ586411A (en)	2012-06-29
JP5806465B2 (ja)	2015-11-10
US20110076719A1 (en)	2011-03-31
AR113492A2 (es)	2020-05-06
AU2008346817B2 (en)	2014-07-24
JP2011507550A (ja)	2011-03-10
MX2010007344A (es)	2010-11-09
SG192471A1 (en)	2013-08-30
HUE043863T2 (hu)	2019-09-30
KR101618144B1 (ko)	2016-05-17
WO2009088713A1 (en)	2009-07-16
PL2240578T3 (pl)	2019-09-30
CN110066782A (zh)	2019-07-30
EP3521422B1 (en)	2021-10-06
EP3521422A1 (en)	2019-08-07
KR20100114057A (ko)	2010-10-22
PT2240578T (pt)	2019-06-19
BRPI0821467B8 (pt)	2021-05-25
US9127264B2 (en)	2015-09-08
AR069892A1 (es)	2010-02-24
ES2897561T3 (es)	2022-03-01

Publication	Publication Date	Title
BRPI0815407A2 (pt)	2014-09-30	Composições e métodos para controlar nematódeos
BRPI0907186A2 (pt)	2015-07-14	Composições proteicas pulverizadas e métodos para sua produção
BRPI0812206A2 (pt)	2014-10-14	Métodos para melhorar o desempenho de proteínas
BRPI0821467A2 (pt)	2014-10-14	Composição, e, métodos pra produzir furina recombinante substancialmente livre de proteína animal, e para utilizar uma composição
BRPI0920670A8 (pt)	2018-03-20	composição nutritiva para promover o desenvolvimento e crescimento sadios
BRPI0807789A2 (pt)	2014-06-24	Composição de ração para animal de estimação, ração para animal de estimação, e, uso de uma composição
BRPI0912123A2 (pt)	2015-07-28	Composições de sal e métodos de produção das mesmas
PL2059223T3 (pl)	2013-03-29	Kompozycja do pielęgnacji skóry
BRPI0915481A2 (pt)	2015-11-10	material e método para produzir o mesmo
DK3118220T3 (da)	2019-09-23	Protein
BRPI0813725A2 (pt)	2014-12-30	Métodos e composições para tratamento de doenças
BRPI0914713A2 (pt)	2017-05-23	composição para cuidado oral
BRPI0821858A2 (pt)	2014-09-30	Composto, composição para cuidado oral, e, método
EP2374452A4 (en)	2015-03-25	NUTRIENT COMPOSITION
BRPI0906501A2 (pt)	2017-06-13	composição compreendendo proteína e gordura dispersas
PT2868315T (pt)	2017-09-04	Formulações melhoradas e métodos para liofilização e liofilizados assim produzidos
DOS2006000058S (es)	2007-09-15	Masticador para animales
BRPI0814971A2 (pt)	2015-02-03	Proteína
BRPI0917564A2 (pt)	2015-11-17	bioensaio para proteína poli-q
BRPI0909885A2 (pt)	2015-10-27	composição decorativa e método para sua utilização
BRPI0807220B1 (pt)	2016-11-16	composição, e, métodos para aumentar a força de compressão de uma composição e para aumentar a retenção de fragrância de uma composição
BRPI0907561A2 (pt)	2015-08-04	Materiais e métodos para aperfeiçoamento da saúde de camarões
BRPI0920850A2 (pt)	2016-09-13	novos compostos e sua utilização
BRPI0913136A2 (pt)	2016-01-05	método para produzir uma peça e peça.
FR2915896B1 (fr)	2011-05-27	Composition cosmetique foisonnee

Legal Events

Date	Code	Title	Description
2016-12-13	B25A	Requested transfer of rights approved	Owner name: BAXALTA GMBH (CH) , BAXALTA INCORPORATED (US)
2017-03-01	B06F	Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
2017-07-04	B07D	Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
2018-04-17	B07E	Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
2018-07-10	B07A	Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
2018-11-13	B06A	Patent application procedure suspended [chapter 6.1 patent gazette]
2019-04-02	B06A	Patent application procedure suspended [chapter 6.1 patent gazette]
2019-08-13	B09A	Decision: intention to grant [chapter 9.1 patent gazette]
2019-10-15	B16A	Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]	Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 15/10/2019, OBSERVADAS AS CONDICOES LEGAIS. (CO) 10 (DEZ) ANOS CONTADOS A PARTIR DE 15/10/2019, OBSERVADAS AS CONDICOES LEGAIS
2021-05-25	B16C	Correction of notification of the grant [chapter 16.3 patent gazette]	Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 19/12/2008 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF
2021-07-13	B25A	Requested transfer of rights approved	Owner name: TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP)